References
- Charbonnel B. Clinical and metabolic effects of the treatment of diabetic patients with gliclazide. “Gliclazide and the Treatment of Diabetes”, H. Keen, A. D. S. Caldwell, M. Murphy, C. H. Bowker. Academic Press, London 1980; 123–128, R. Soc. Med. Int. Congr. Symp. Series No. 201. Charbonnel B. Clinical and metabolic effects of the treatment of diabetic patients with gliclazide. “Gliclazide and the Treatment of Diabetes”, H. Keen, A. D. S. Caldwell, M. Murphy, C. H. Bowker. Academic Press, London 1980; 123–128, R. Soc. Med. Int. Congr. Symp. Series No. 20
- Donnet J. P. Evaluation métabolique et pondérale de l'efficacité à long terme du Diamicron dans le diabète non insulino-dependent. Vie Méd. 1982; 10: 725–7282. Donnet J. P. Evaluation métabolique et pondérale de l'efficacité à long terme du Diamicron dans le diabète non insulino-dependent. Vie Méd. 1982; 10: 725–728
- Stowers J. M., Borthwick L. J. Oral hypoglycaemic drugs: clinical pharmacology and therapeutic use. Curr. Ther. 1977; 18: 101–1253. Stowers J. M., Borthwick L. J. Oral hypoglycaemic drugs: clinical pharmacology and therapeutic use. Curr. Ther. 1977; 18: 101–125